Beneficial response to interleukin 1 receptor antagonist in traps

This publication has 8 references indexed in Scilit:

• Interleukin-1–Receptor Antagonist in the Muckle–Wells Syndrome
  New England Journal of Medicine, 2003
• Targeted Disruption of Pyrin, the FMF Protein, Causes Heightened Sensitivity to Endotoxin and a Defect in Macrophage Apoptosis
  Published by Elsevier ,2003
• Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients
  Rheumatology, 2003
• De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal‐onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin‐associated autoinflammatory diseases
  Arthritis & Rheumatism, 2002
• Long‐term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin‐1 receptor antagonist) in patients with rheumatoid arthritis: Extension phase of a randomized, double‐blind, placebo‐controlled trial
  Arthritis & Rheumatism, 2002
• Lack of isoprenoid products raises ex vivo interleukin‐1β secretion in hyperimmunoglobulinemia D and periodic fever syndrome
  Arthritis & Rheumatism, 2002
• The TNF Receptor-Associated Periodic Syndrome (TRAPS)
  Medicine, 2002
• Genetic analysis as a valuable key to diagnosis and treatment of periodic Fever.
  Archives of internal medicine (1960), 2001